EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination

Valarmathy Murugaiah, Simon J Watson iD, Robert F Cunliffe, Nigel J Temperton iD, Stevo T Reece, Paul Kellam iD, John S Tregoning iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Valarmathy Murugaiah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: B-Lymphocytes, Influenza Vaccines, Antibodies, Viral, Orthomyxoviridae Infections. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of a universal influenza vaccine likely requires an understanding of previous exposure to influenza virus (through vaccination or infection) and how that shapes the antibody repertoire to vaccination, sometimes called original antigenic sin or antigenic imprinting. While animal models can have a much more defined exposure history, they lack a human B-cell repertoire. Transgenic mice with the complete human immunoglobulin locus enable studies of controlled infection history leading to human-like antibody evolution. Here we evaluated responses to influenza in the Intelliselect transgenic mouse (the Kymouse). We show the Kymouse is susceptible to disease following infection with either H1N1, H3N2, or B/Yamagata influenza viruses and that it induces a robust binding and neutralizing antibody response to all 3 strains of influenza virus. This study demonstrates that human B-cell repertoire mice can be used for influenza virus studies, providing a tool for further interrogation of the antibody response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesInfluenza VaccinesAntibodies, ViralOrthomyxoviridae InfectionsInfluenza, HumanAnimalsMice, TransgenicHumansMiceInfluenza B virusInfluenza A Virus, H1N1 SubtypeDisease Models, AnimalInfluenza A Virus, H3N2 SubtypeAntibodies, NeutralizingVaccinationAntibody Formation

Stichwörter der Autor:innen

antibodyantigenic sinhumanizedinfluenzauniversal vaccine

Substanzen

Influenza VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom.
  • Viral Pseudotype Unit, University of Kent and Greenwich, Chatham, United Kingdom.

ORCID-Profile: Simon J Watson, Nigel J Temperton, Paul Kellam, John S Tregoning

Förderung

  • Gates Foundation
  • Bill & Melinda Gates Foundation

Zitieren

APA

Murugaiah, V., Watson, S. J., Cunliffe, R. F., Temperton, N. J., Reece, S. T., Kellam, P., & Tregoning, J. S. (2025). A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae472

Vancouver

Murugaiah V, Watson SJ, Cunliffe RF, Temperton NJ, Reece ST, Kellam P, et al. A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae472

BibTeX
@article{Murugaiah2025,
  author = {Murugaiah, Valarmathy and Watson, Simon J and Cunliffe, Robert F and Temperton, Nigel J and Reece, Stevo T and Kellam, Paul and Tregoning, John S},
  title = {A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae472}
}
Kostenlos starten →